Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery

Clinical Cardiology

Volumn 36, Issue 8, 2013, Pages 456-461

  Raju, Manjunath G ^a   Pachika, Ajay ^b   Punnam, Sujeeth R ^c   Gardiner, Joseph C ^d   Shishehbor, Mehdi H ^a   Kapadia, Samir R ^a   Abela, George S ^e  

^a LERNER RESEARCH INSTITUTE   (United States)

^b University of Louisville School of Medicine   (United States)

^c Delta Heart and Medical Clinic   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL SURGERY; AGED; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PERCUTANEOUS CORONARY INTERVENTION; PROPENSITY SCORE; RISK REDUCTION; SURGICAL MORTALITY; TREATMENT OUTCOME; UROLOGIC SURGERY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PROPENSITY SCORE; RETROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84882252407     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22135     Document Type: Article

References (40)

1. Mangano DT, Browner WS, Hollenberg M, et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The study of perioperative ischemia research group. N Engl J Med. 1990; 323: 1781-1788.
2. Shah KB, Kleinman BS, Rao TL, et al. Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg. 1990; 70: 240-247.
3. Badner NH, Knill RL, Brown JE, et al. Myocardial infarction after noncardiac surgery. Anesthesiology. 1998; 88: 572-578.
4. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977; 297: 845-850.
5. Zaman AG, Helft G, Worthley SG, et al. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis. 2000; 149: 251-266.
6. Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (decrease-iv). Ann Surg. 2009; 249: 921-926.
7. Bangalore S, Wetterslev J, Pranesh S, et al. Perioperative beta blockers in patients having non- cardiac surgery: a meta-analysis. Lancet. 2008; 372: 1962-1976.
8. Crisby M, Nordin-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: Implications for plaque stabilization. Circulation. 2001; 103: 926-933.
9. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4 s). Lancet. 1994; 344: 1383-1389.
10. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The long-term intervention with pravastatin in ischaemic disease (lipid) study group. N Engl J Med. 1998; 339: 1349-1357.
11. Pan W, Pintar T, Anton J, et al. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004; 110: II45-II49.
12. Thielmann M, Neuhauser M, Marr A, et al. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2007; 134: 1143-1149.
13. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003; 107: 1848-1851.
14. O'Neil-Callahan K, Katsimaglis G, Tepper MR, et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the statins for risk reduction in surgery (starrs) study. J Am Coll Cardiol. 2005; 45: 336-342.
15. Ward RP, Leeper NJ, Kirkpatrick JN, et al. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol. 2005; 104: 264-268.
16. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg. 2008; 106: 685-712.
17. Thygesen K, Alpert JS, White HD,. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007; 50: 2173-2195.
18. Cannon CP, Battler A, Brindis RG, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001; 38: 2114-2130.
19. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. Multicenter study of Perioperative Ischemia Research Group. JAMA. 1996; 276: 300-306.
20. Hosmer DW, Lemeshow S,. Applied Logistic Regression. New York, NY: Wiley; 2000.
21. Luo Z, Gardiner JC, Bradley CJ,. Applying propensity score methods in medical research: pitfalls and prospects. Med Care Res Rev. 2010; 67: 528-554.
22. Wilhelmsen L, Pyorala K, Wedel H, et al. Risk factors for a major coronary event after myocardial infarction in the scandinavian simvastatin survival study (4 s). Impact of predicted risk on the benefit of cholesterol-lowering treatment. Eur Heart J. 2001; 22: 1119-1127.
23. Fauchier L, Clementy N, Babuty D,. Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials. Curr Opin Cardiol. 2013; 28: 7-18.
24. Chopra V, Wesorick DH, Sussman JB, et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta- analysis. Arch Surg. 2012; 147: 181-189.
25. Mills EJ, Rachlis B, Wu P, et al. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008; 52: 1769-1781.
26. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation. 1998; 97: 1440-1445.
27. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med. 2008; 359: 2195-2207.
28. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005; 352: 20-28.
29. McCarey DW, McInnes IB, Madhok R, et al. Trial of atorvastatin in rheumatoid arthritis (tara): double-blind, randomised placebo-controlled trial. Lancet. 2004; 363: 2015-2021.
30. Undas A, Brummel KE, Musial J, et al. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation. 2001; 103: 2248-2253.
31. Dangas G, Badimon JJ, Smith DA, et al. Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol. 1999; 33: 1294-1304.
32. Mayer J, Eller T, Brauer P, et al. Effects of long-term treatment with lovastatin on the clotting system and blood platelets. Ann Hematol. 1992; 64: 196-201.
33. Abela GS, Vedre A, Janoudi A, et al. Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. Am J Cardiol. 2011; 107: 1710-1717.
34. Ellis SG, Hertzer NR, Young JR, et al. Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery. Am J Cardiol. 1996; 77: 1126-1128.
35. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation. 2002; 106: 804-808.
36. Abela GS, Aziz K, Vedre A, et al. Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am J Cardiol. 2009; 103: 959-968.
37. Ray KK, Cannon CP,. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol. 2005; 46: 1425-1433.
38. Le Manach Y, Coriat P, Collard CD, et al. Statin therapy within the perioperative period. Anesthesiology. 2008; 108: 1141-1146.
39. Hindler K, Shaw AD, Samuels J, et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology. 2006; 105: 1260-1272; quiz 1289-1290.
40. Xu SZ, Zhong W, Watson NM, et al. Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2. J Thromb Haemost. 2008; 6: 692-700.